Incorporated in Bhopal in January 2024, Curiscent Pharma began with a pharmaceutical portfolio — and a clear intention to become something bigger over time.
2 January 2024, registered with the Registrar of Companies, Gwalior.
U46497MP2024PTC069219 — active private limited company.
Authorised capital of ₹15 lakh; paid-up capital of ₹1 lakh.
H.No. A-14, Asnani Santafe, Phase-1, Village Katara, Bhopal, Madhya Pradesh.
Curiscent Pharma Private Limited started as a young pharmaceutical company — but the objective was never simply to create another trading entity. The idea from day one has been to build Curiscent into a trusted healthcare organisation, beginning with pharmaceuticals and gradually creating a broader healthcare infrastructure around it.
That means the pharmaceutical portfolio — product names, compositions, therapeutic categories, positioning and commercial offering — is the first practical foundation. Curiscent products are already visible on Indian medicine marketplaces, confirming that the portfolio is not merely a concept but a working business.
Curiscent Pharma Private Limited is incorporated and registered as an active private limited company based in Bhopal, Madhya Pradesh.
Product names, compositions, therapeutic positioning, packaging and the Curiscent visual identity are developed across 16+ formulations.
Curiscent is listed as the marketer of products including Curcet-M, Curpara-P, Curpara-SP and Curpanta-DSR on Indian medicine marketplaces.
A working pharmaceutical portfolio and identity are established; distribution network, PCD franchise partnerships, third-party manufacturing and bulk supply capability are being built out.
Seva · Swasth · Samraddhi represents the intended identity of Curiscent: Curiscent exists to contribute to healthcare through service, health and sustainable prosperity — not simply to sell medicines.
Service to patients, doctors, hospitals and society — the foundation of every relationship Curiscent builds, from prescriber to patient.
Improving health through responsible healthcare and pharmaceutical products, backed by quality-assured manufacturing standards.
Creating sustainable growth for the company, its partners, healthcare professionals and the larger network of franchisees, distributors and manufacturing partners around it.
To grow Curiscent from a pharmaceutical portfolio into a nationwide commercial network — connecting products, distribution partners, PCD franchisees and manufacturing capability under one trusted brand.
To develop safe, effective and accessible pharmaceutical products, presented professionally to doctors, distributors, hospitals and institutions — with service and sustainability at the centre.
Curiscent isn't at the end of its journey — the next decisions on distribution, franchise partnerships, manufacturing and bulk supply will shape what kind of company it becomes.
Public corporate records list the following directors from the date of incorporation.
Director of Curiscent Pharma Private Limited since incorporation on 2 January 2024.
Director of Curiscent Pharma Private Limited since incorporation on 2 January 2024.
We're happy to share our company profile and product portfolio for doctors, distributors and institutional partners.
